审查COVID-19疫苗安全性辩论
Khalid Bin Abdulrahman1, Amro Bin Abdulrahman2
1Department of Medical Education, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Human vaccines & immunotherapeutics
|December 18, 2024
概括
历史上的疫苗安全辩论与当前的冠状病毒病-19 (COVID-19) 疫苗接种问题相呼应. 一项大型研究确定了罕见副作用的先前存在的安全指标,强调了明确的沟通和强有力的监测.
科学领域:
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 疫苗安全性讨论有很长的历史,过去的争议围绕麻疹,疹,红疹和流感疫苗.
- 关于疫苗安全性的公众怀疑往往是由错误信息和事证据放大.
- 经常出现的公众犹的模式强调了基于证据的沟通的必要性.
研究的目的:
- 检查COVID-19疫苗接种后特定不良事件的现有安全指标.
- 通过介绍一项大规模研究的发现,为正在进行的关于疫苗安全的讨论做出贡献.
- 澄清疫苗安全研究中关联与因果关系之间的区别.
主要方法:
- 进行了一项跨国研究,分析了大量样本.
- 这项研究的重点是确定心肌炎,心周炎,吉-巴雷综合征和脑静脉鼻血栓症的现有安全指标.
- 该研究的设计旨在为疫苗安全性评估提供可靠的数据.
主要成果:
- 该研究确定了针对特定罕见不良事件的先前存在的安全指标.
- 这些发现有助于了解COVID-19疫苗的安全性.
- 这项研究强调了区分单纯的关联与被证明的因果关系的重要性.
结论:
- 开放的沟通和彻底的科学调查对于解决疫苗犹至关重要.
- 优先考虑透明地传播疫苗安全数据,包括风险和益处,至关重要.
- 建立强大的营销后监测系统可以增强公众对疫苗安全监测的信心.
更多相关视频
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.4K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.5K
相关概念视频
Vaccinations
44.1K
Overview
44.1K
CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Cross-reactivity
31.0K
Overview
31.0K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338
